Skip to main content

iPower Reports Fiscal Q2 2026 Results and Completes Strategic Operating Reset

RANCHO CUCAMONGA, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”) today reported financial results for the fiscal second quarter ended December 31, 2025. Revenue was $7.1 million, reflecting the Company’s deliberate supply chain restructuring and transition to predominantly U.S.-based sourcing during the quarter, while gross profit was $3.1 million and gross margin remained strong at 44.0%. Total operating expenses declined 28% year-over-year to $5.6 million compared to the quarter ended December 31, 2024. Net loss attributable to iPower was $1.2 million, or $(1.08) per share. The Company reported $2.0 million of cash and cash equivalents, $2.2 million of restricted cash, and approximately $2.2 million of digital assets. During December 2025, the Company implemented a Digital Asset...

Continue reading

Abony Acquisition Corp. I Announces Closing of $230 Million Initial Public Offering Including Exercise of Underwriter’s Over-Allotment Option in Full

AUSTIN, TX, Feb. 20, 2026 (GLOBE NEWSWIRE) — Abony Acquisition Corp. I (Nasdaq: AACOU) (the “Company”) today announced the closing of its initial public offering of 23,000,000 units, which includes 3,000,000 units issued pursuant to the exercise by the underwriter of its over-allotment option in full, at a public offering price of $10.00 per unit. Each unit sold in the offering consists of one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. The units are listed on the Global Market tier of the Nasdaq Stock Market LLC (“Nasdaq”) and commenced trading under the ticker symbol “AACOU” on February 19, 2026. Once the securities comprising the units begin separate trading, the Class...

Continue reading

Electra Upsizes At-The-Market Offering

TORONTO, Feb. 20, 2026 (GLOBE NEWSWIRE) — Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) has announced that it has upsized its previously announced At the Market Offering Program (the “ATM”), pursuant to which the Company may offer and sell, at its discretion and from time to time, through H.C. Wainwright & Co., LLC (“Wainwright”), common shares in the capital of the Company (the “Common Shares”) having an aggregate offering price of up to US$25,000,000. The ATM was established pursuant to an At The Market Offering Agreement (the “ATM Agreement”) entered into with Wainwright and dated June 26, 2025. The US$25,000,000 aggregate offering amount includes the amount of sales previously made by the Company under the ATM Agreement pursuant to the Company’s prospectus supplement dated...

Continue reading

22nd Century Group Preliminarily Reports Fourth Quarter and Full Year 2025 Financial Results

Balance sheet strength, ended 2025 with $7.1 million in cash and debt free, supports transition to growth Continued VLN® commercial expansion drives shift toward higher margin proprietary branded products MOCKSVILLE, N.C., Feb. 20, 2026 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today announced select, preliminary and unaudited financial results and operating metrics for the fourth quarter and full year ended December 31, 2025. The company anticipates releasing fourth quarter and full year 2025 earnings on or before March 31, 2026, and will host a conference call for investors and financial analysts. The final date and details of the conference call will separately...

Continue reading

U.S. Global Investors Reports 12% Sequential Growth in Assets Under Management in Q2 of Fiscal 2026

SAN ANTONIO, Feb. 20, 2026 (GLOBE NEWSWIRE) — U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a registered investment advisory firm1 with longstanding experience in global markets and specialized sectors, today reported financial results for the second quarter of fiscal 2026 ended December 31, 2025. Total assets under management (AUM) were approximately $1.5 billion at quarter-end, representing a 12% increase from the prior quarter and 5% higher than AUM at the end of the year-ago quarter. This rose to $1.7 billion in total AUM as of Thursday, February 19. Operating revenue increased by $259,000, or 11.5%, compared to the prior quarter, and by $279,000 compared to the quarter ended December 31, 2024. Additionally, the Company’s expenses decreased by $172,000 in the current quarter compared to the same quarter last year....

Continue reading

Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates

2025 Total Revenue of $634M, up 17% Year-over-Year at CER Cash Position of $294M, a $44M Increase in 2025 Proposed Acquisition by BioMarin Expected to Close in Q2 2026, Subject to Closing Conditions PRINCETON, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), a leading, global biotechnology company with a clear and compelling mission to develop and deliver transformative medicines for people living with rare diseases, today announced financial results for the full year ended December 31, 2025. Full-Year 2025 Financial Highlights:Total revenues for the full year 2025 were $634.2 million, reflecting strong operational growth measured at constant exchange rates (CER)1 of 17% and a currency tailwind of ~$14 million. Fourth quarter total revenues were $185.2 million up 24%, or 20% at CER1.(in thousands) Three...

Continue reading

Surge Copper Announces Berg Project Acceptance into BC Critical Minerals Office

Vancouver, British Columbia, Feb. 20, 2026 (GLOBE NEWSWIRE) — Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) is pleased to announce the British Columbia government’s acceptance of the Berg Project into the Critical Minerals Office (“CMO”). The Berg Project aligns with both national critical minerals objectives and the recently announced Western Canadian Critical Minerals Strategy, positioning the project within provincial and federal priorities to strengthen secure, responsibly produced mineral supply chains. If developed as envisioned, Berg’s projected output of critical minerals, including copper and molybdenum, would rank among the largest in Canada, reinforcing its strategic importance to British Columbia’s long-term economic and industrial objectives. Through the Critical...

Continue reading

Century Aluminum Company Statement on U.S. Supreme Court IEEPA Ruling

CHICAGO, Feb. 20, 2026 (GLOBE NEWSWIRE) — Century Aluminum Company (NASDAQ: CENX) today issued the following statement regarding the U.S. Supreme Court’s decision on the tariffs imposed under the International Emergency Economic Powers Act (IEEPA). Century Aluminum proudly stands with President Donald J. Trump and his America First trade policies, which have been instrumental in ensuring a level playing field for American industry and workers and restoring the U.S. industrial base. Those trade policies include the IEEPA tariffs addressed in today’s Supreme Court ruling, as well as the Section 232 steel and aluminum tariffs which were not impacted by the decision and remain in full force and effect. President Trump’s trade policies have strengthened our commitment to reshoring American production of primary aluminum – a critical...

Continue reading

Update for the James Bay Niobium Project

MONTRÉAL, Feb. 20, 2026 (GLOBE NEWSWIRE) — NioBay Metals Inc. (“NioBay” or the “Company”) (TSX-V  NBY) (OTCQB: NBYCF), provides an update on its wholly-owned James Bay niobium project (the “Project”). The Company recently became aware of a letter dated February 18, 2026 (the “Letter”), issued by the Chief of the Moose Cree First Nation (“MCFN”) and subsequently posted on Facebook. NioBay wishes to reiterate that it will carry out its exploration program in a manner that respects the rights of the MCFN as well as all applicable environmental laws and regulations and in full compliance with the permit issued by the Ontario government. NioBay is committed to working in alignment with the local community through the use of local contractors, job creation, strategic partnerships, community contributions, and the development of collaborative...

Continue reading

Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option

VICTORIA, British Columbia, Feb. 20, 2026 (GLOBE NEWSWIRE) — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, is pleased to announce the successful closing of its previously announced public offering (the “Offering”) of 7,607,145 common shares of the Company (the “Common Shares”), which includes the full exercise of the option to purchase additional shares granted to the underwriters, at a price to the public of US$7.00 per Common Share, and pre-funded warrants to purchase up to 1,428,571 Common Shares in lieu thereof (the “Pre-Funded Warrants”) at a price of US$6.99999 per Pre-Funded...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.